Jun An Lu

Director/Miembro de la Junta en EpimAb Biotherapeutics, Inc. .

35 años

Commercial Services

Health Technology

Perfil

Jun An Lu currently works at EpimAb Biotherapeutics, Inc., as Director.
Mr. Lu also formerly worked at Inmyshow Digital Technology (Group) Co., Ltd., as Securities Representative.

Cargos activos de Jun An Lu

Empresas	Cargo	Inicio
EpimAb Biotherapeutics, Inc. EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016.	Director/Miembro de la Junta	-

Todos los cargos activos de Jun An Lu

Antiguos cargos conocidos de Jun An Lu.

Empresas	Cargo	Fin
INMYSHOW DIGITAL TECHNOLOGY(GROUP)CO.,LTD.	Contacto de Relaciones con Inversores	26/01/2017

Ver el detalle de la experiencia de Jun An Lu.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jun An Lu.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
INMYSHOW DIGITAL TECHNOLOGY(GROUP)CO.,LTD.	Commercial Services

Empresas privadas	1
EpimAb Biotherapeutics, Inc. EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016.	Health Technology